BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36726200)

  • 61. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
    Ozaki Y; Koide M; Furuya Y; Ninomiya T; Yasuda H; Nakamura M; Kobayashi Y; Takahashi N; Yoshinari N; Udagawa N
    PLoS One; 2017; 12(9):e0184904. PubMed ID: 28937990
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Identification of LRRc17 as a negative regulator of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiation.
    Kim T; Kim K; Lee SH; So HS; Lee J; Kim N; Choi Y
    J Biol Chem; 2009 May; 284(22):15308-16. PubMed ID: 19336404
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Regulation of RANKL-induced osteoclastogenesis by RING finger protein RNF114.
    Lin B; Ke Q; Leaman DW; Goel V; Agarwal A
    J Orthop Res; 2018 Jan; 36(1):159-166. PubMed ID: 28708287
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues.
    Kartsogiannis V; Zhou H; Horwood NJ; Thomas RJ; Hards DK; Quinn JM; Niforas P; Ng KW; Martin TJ; Gillespie MT
    Bone; 1999 Nov; 25(5):525-34. PubMed ID: 10574572
    [TBL] [Abstract][Full Text] [Related]  

  • 65. TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro.
    Subramaniam M; Gorny G; Johnsen SA; Monroe DG; Evans GL; Fraser DG; Rickard DJ; Rasmussen K; van Deursen JM; Turner RT; Oursler MJ; Spelsberg TC
    Mol Cell Biol; 2005 Feb; 25(3):1191-9. PubMed ID: 15657444
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-κB ligand expression in osteoblasts.
    Tachi K; Takami M; Zhao B; Mochizuki A; Yamada A; Miyamoto Y; Inoue T; Baba K; Kamijo R
    Cell Tissue Res; 2010 Nov; 342(2):213-20. PubMed ID: 20941510
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Roles of chemokine receptor CX3CR1 in maintaining murine bone homeostasis through the regulation of both osteoblasts and osteoclasts.
    Hoshino A; Ueha S; Hanada S; Imai T; Ito M; Yamamoto K; Matsushima K; Yamaguchi A; Iimura T
    J Cell Sci; 2013 Feb; 126(Pt 4):1032-45. PubMed ID: 23264747
    [TBL] [Abstract][Full Text] [Related]  

  • 68. LOX Fails to Substitute for RANKL in Osteoclastogenesis.
    Tsukasaki M; Hamada K; Okamoto K; Nagashima K; Terashima A; Komatsu N; Win SJ; Okamura T; Nitta T; Yasuda H; Penninger JM; Takayanagi H
    J Bone Miner Res; 2017 Mar; 32(3):434-439. PubMed ID: 27606829
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Kruppel-like factor 4 attenuates osteoblast formation, function, and cross talk with osteoclasts.
    Kim JH; Kim K; Youn BU; Lee J; Kim I; Shin HI; Akiyama H; Choi Y; Kim N
    J Cell Biol; 2014 Mar; 204(6):1063-74. PubMed ID: 24616223
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [A Novel Oral Anti-osteoporosis Drug with Osteogenesis-promoting Effects via Osteoblast Differentiation].
    Kitao T; Ito Y; Fukui M; Yamamoto M; Shoji Y; Takeda S; Shirahase H
    Yakugaku Zasshi; 2019; 139(1):19-25. PubMed ID: 30606923
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Low levels of cadmium exposure affect bone by inhibiting Lgr4 expression in osteoblasts and osteoclasts.
    Wang M; Liu J; Zhu G; Chen X
    J Trace Elem Med Biol; 2022 Sep; 73():127025. PubMed ID: 35772369
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Action of RANKL and OPG for osteoclastogenesis.
    Kobayashi Y; Udagawa N; Takahashi N
    Crit Rev Eukaryot Gene Expr; 2009; 19(1):61-72. PubMed ID: 19191757
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
    Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
    Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Daily administration of eldecalcitol (ED-71), an active vitamin D analog, increases bone mineral density by suppressing RANKL expression in mouse trabecular bone.
    Harada S; Mizoguchi T; Kobayashi Y; Nakamichi Y; Takeda S; Sakai S; Takahashi F; Saito H; Yasuda H; Udagawa N; Suda T; Takahashi N
    J Bone Miner Res; 2012 Feb; 27(2):461-73. PubMed ID: 22052469
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties.
    Wang CJ; Chen IP; Koczon-Jaremko B; Boskey AL; Ueki Y; Kuhn L; Reichenberger EJ
    Bone; 2010 May; 46(5):1306-15. PubMed ID: 20117257
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ovariectomy increases RANKL protein expression in bone marrow adipocytes of C3H/HeJ mice.
    Beekman KM; Zwaagstra M; Veldhuis-Vlug AG; van Essen HW; den Heijer M; Maas M; Kerckhofs G; Parac-Vogt TN; Bisschop PH; Bravenboer N
    Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1050-E1054. PubMed ID: 31526291
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regulation of Hedgehog signaling Offers A Novel Perspective for Bone Homeostasis Disorder Treatment.
    Lv WT; Du DH; Gao RJ; Yu CW; Jia Y; Jia ZF; Wang CJ
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426273
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Osteoblastic γ-aminobutyric acid, type B receptors negatively regulate osteoblastogenesis toward disturbance of osteoclastogenesis mediated by receptor activator of nuclear factor κB ligand in mouse bone.
    Takahata Y; Takarada T; Hinoi E; Nakamura Y; Fujita H; Yoneda Y
    J Biol Chem; 2011 Sep; 286(38):32906-17. PubMed ID: 21828041
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lack of CD47 impairs bone cell differentiation and results in an osteopenic phenotype in vivo due to impaired signal regulatory protein α (SIRPα) signaling.
    Koskinen C; Persson E; Baldock P; Stenberg Å; Boström I; Matozaki T; Oldenborg PA; Lundberg P
    J Biol Chem; 2013 Oct; 288(41):29333-44. PubMed ID: 23990469
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Transgenic overexpression of tartrate-resistant acid phosphatase is associated with induction of osteoblast gene expression and increased cortical bone mineral content and density.
    Gradin P; Hollberg K; Cassady AI; Lång P; Andersson G
    Cells Tissues Organs; 2012; 196(1):68-81. PubMed ID: 22248481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.